BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production Elizabeth Masencup July 22, 2024
BWXT to Evaluate Locations for Building New Nuclear TRISO Fuel Production Facility to Support Advanced Reactor Deployment Elizabeth Masencup July 18, 2024
BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming Elizabeth Masencup June 17, 2024
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant Elizabeth Masencup June 14, 2024
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration Elizabeth Masencup June 7, 2024
BWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier Group Elizabeth Masencup April 29, 2024
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market Elizabeth Masencup April 19, 2024
